Safety and Outcome of Retreatment with [177Lu]LuPSMA-I&T Radioligand Therapy (PRLT) in Metastatic Castration Resistant Prostate Cancer

被引：0
|
作者：
Santo, G. [1 ,2 ]
Di Santo, G. [1 ]
Sviridenko, A. [1 ]
Kiasatdolatabadi, M. [1 ]
Bayerschmidt, S. [1 ]
Wirth, L. [1 ]
Scherbauer, F. [1 ]
Lehmann, P. [1 ]
von Guggenberg, E. [1 ]
Decristoforo, C. [1 ]
Virgolini, I. [1 ]
机构：
[1] Med Univ Innsbruck, Dept Nucl Med, Innsbruck, Austria
[2] Magna Graecia Univ Catanzaro, Catanzaro, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-274
引用
收藏
页码：S418 / S419
页数：2
相关论文
共 50 条
  • [31] 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy
    Baum, Richard P.
    Kulkarni, Harshad R.
    Schuchardt, Christiane
    Singh, Aviral
    Wirtz, Martina
    Wiessalla, Stefan
    Schottelius, Margret
    Mueller, Dirk
    Klette, Ingo
    Wester, Hans-Juergen
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (07) : 1006 - 1013
  • [32] Genetic analysis of metastatic castration resistant prostate cancer patients treated with Lu-177 PSMA radioligand therapy
    Yilmaz, Burcak
    Chalker, Cameron
    Yu, Yun
    Kaempf, Andy
    Mittra, Erik
    Mallak, Nadine
    Sokolova, Alexandra
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] Outcome and prognostic predictors of Lu177-PSMA radioligand therapy in metastatic castration-resistant prostate cancer (Asian population study)
    Chua, W.
    Lam, W.
    Tong, A.
    Sultana, R.
    Kua, S.
    Kanesvaran, R.
    Wong, A.
    Tay, K.
    Cheng, T.
    Ng, D.
    Thang, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S400 - S401
  • [34] Combining enzalutamide and [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
    Houede, Nadine
    Hebert, Kevin
    LANCET ONCOLOGY, 2024, 25 (05): : 531 - 533
  • [35] Organ and tumor dosimetry including method simplification for [177Lu]Lu-PSMA-I&T for treatment of metastatic castration resistant prostate cancer
    Karimzadeh, Amir
    Schatz, Linus
    Sauer, Markus
    Apostolova, Ivayla
    Buchert, Ralph
    Klutmann, Susanne
    Lehnert, Wencke
    EJNMMI PHYSICS, 2024, 11 (01):
  • [36] Biodistribution and dosimetry of [177Lu]Lu-SibuDAB in patients with metastatic castration-resistant prostate cancer
    Ritt, Philipp
    Nicolai, Heinz
    Fernandez, Rene
    Soza-Ried, Cristian
    Amaral, Horacio
    Krieger, Korbinian
    Mapanao, Ana Katrina
    Rotger, Amanda
    Zhernosekov, Konstantin
    Schibli, Roger
    Mueller, Cristina
    Kramer, Vasko
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [37] 177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer
    Braeuer, Axel
    Grubert, Lena Sophie
    Roll, Wolfgang
    Schrader, Andres Jan
    Schaefers, Michael
    Boegemann, Martin
    Rahbar, Kambiz
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) : 1663 - 1670
  • [38] 177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer
    Axel Bräuer
    Lena Sophie Grubert
    Wolfgang Roll
    Andres Jan Schrader
    Michael Schäfers
    Martin Bögemann
    Kambiz Rahbar
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1663 - 1670
  • [39] Safety and efficacy of 177Lu-PSMA-I&T Radioligand Therapy in Octogenarians with metastatic castration-resistant prostate cancer: Report on eighty patients over age of eighty
    Langbein, Thomas
    Rauscher, Isabel
    Knorr, Karina
    Retz, Margitta
    Grigorascu, Sonia
    Hansen, Kimberley
    D'Alessandria, Calogero
    Hans-Juergen, Wester
    Gschwend, Juergen
    Weber, Wolfgang
    Eiber, Matthias
    Tauber, Robert
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [40] Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [177Lu]Lu-PSMA I&T
    Hartrampf, Philipp E.
    Weinzierl, Franz-Xaver
    Serfling, Sebastian E.
    Pomper, Martin G.
    Rowe, Steven P.
    Higuchi, Takahiro
    Seitz, Anna Katharina
    Kuebler, Hubert
    Buck, Andreas K.
    Werner, Rudolf A.
    CANCERS, 2022, 14 (03)
12345